SKYSTAR BIO-PHARMACEUTICAL CO
DelistedCIK 1076939fmd_0E56YQB7AQPK3YTHRRSZSVA5C6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2014, 18 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|
| Cost of revenue | 22 | 27 | 15 | 21 |
| Net interest income | (0) | (0) | (1) | (1) |
| Gross profit | 26 | 26 | 18 | 21 |
| Research and development | 1 | 3 | 2 | 1 |
| Total operating expenses | 7 | 11 | 10 | 8 |
| Operating income | 18 | 15 | 9 | 13 |
| Interest expense | – | – | 1 | – |
| Interest and investment income | – | – | 0 | 0 |
| Other non-operating income (expense) | (1) | 1 | (0) | (0) |
| Income before taxes | 17 | 17 | 8 | 13 |
| Income tax expense | 3 | 3 | 2 | 2 |
| Net income from continuing operations | 14 | 14 | 6 | 11 |
| Net income | 14 | 14 | 6 | 11 |